Retatrutide + Tesamorelin

Advanced Peptide Research Bundle

Explore two distinct peptide research compounds in one convenient bundle. Combining Tesamorelin and Retatrutide, this research-focused pairing brings together two peptides with different mechanisms of action involving growth hormone signaling and metabolic pathways. Tesamorelin is a growth hormone-releasing peptide that acts on the pituitary gland to stimulate endogenous growth hormone production. Research has explored its role in growth hormone signaling, body composition, and visceral fat metabolism. Retatrutide is an investigational triple agonist peptide that targets GLP-1, GIP, and glucagon receptors. Its unique mechanism has attracted significant research interest in appetite regulation, energy balance, glucose metabolism, and body weight management.

Bundle Highlights

• Two distinct peptide research compounds in one bundle
• Research interest in growth hormone signaling and metabolic pathways
• Combines different mechanisms of action for scientific investigation
• Suitable for laboratory and research purposes only

Research Overview

This bundle brings together two compounds of interest in ongoing research involving body composition, metabolic function, and hormonal signaling. Important: These compounds are intended strictly for laboratory research purposes only. They are not approved for human consumption, therapeutic use, or self-administration. Retatrutide remains an investigational compound.